Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MRPL27 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SLC9A8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KIAA1549 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DGCR6L - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
NASP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
COQ4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ATP6V1D - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DTYMK - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
JMJD8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GAREM1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC25A14 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MAP3K7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PPP2R3C - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
R3HCC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EIF3I - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMF1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FBXW5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RPA2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on